Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Growth Failure clinical trials
1 of 5 indexed Growth Failure trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Growth Failure: 5 US clinical trials tracked, 1 recruiting.
Growth Failure is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Arkansas Children's Hospital Research Institute, running 1 of these trials.
Enrollment posture brief
Registry condition growth-failure
OPEN 1 | RECR 20% | LATE 0 | EARLY 0 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Growth Failure lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Growth Failure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Growth Failure is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Growth Failure research.
Arkansas Children's Hospital Research Institute accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Growth Failure enrolment sits around 118 participants.
Median target enrolment is 118 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Growth Failure splits between interventional and observational designs.
3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Targeted Fortification of Donor Breast Milk in Preterm Infants
Columbia University
NCT04294368
A Cohort Study of the Intestinal Microbiota of Premature Infants
University of California, Davis
NCT03717584
Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk
University of Alabama at Birmingham
NCT04325308
Is There a Microbiome Associated With Poor Growth in Preterm Infants?
University of Texas Southwestern Medical Center
NCT03761498
Nutritional Stimulation of Growth in Children With Short Stature
Arkansas Children's Hospital Research Institute
NCT04226586
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Growth Failure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Growth Failure trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Growth Failure page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Growth Failure trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Arkansas Children's Hospital Research Institute sponsors the most Growth Failure trials on record, review their full trial history before evaluating a specific study. See Arkansas Children's Hospital Research Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Growth Failure condition card totals 5 registered trials; most-linked intervention Essential Amino Acid (EAA) group; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.